Season 3 Episode 08: Corbus & Penn: Collaborating on Rare Disease R&D | Growing Greater
This week on Growing Greater we learn of rare and serious systemic autoimmune condition known as dermatomyositis. We learn of Corbus Pharmaceuticals’ collaboration with University of Pennsyvalnia on a Phase 2 study, which has shown positive results. Matt Cabrey, Executive Director of Select Greater Philadelphia, a council of the Chamber of Commerce for Greater Philadelphia talks with Corbus Co-Founder and CEO, Yuval Cohen who shares insights about the company’s mission and dedication to research in rare diseases. We are also joined by lead investigator Dr. Victoria Werth, Professor of Dermatology and Medicine at the University of Pennsylvania School of Medicine and Chief of Dermatology at the Philadelphia Veterans Administration Medical Center. Dr. Werth provides perspective on the clinical studies and the collaboration between Corbus and Penn.